Brilliant Study: Assessing Cognition in Myeloma Patients Undergoing Transplant

Completed

Conditions studied: Stem Cell Transplant Complications

In brief

The overall objectives in this study are to identify patterns of cognitive impairment pre- and post-transplant, to assess the similarities of scores of the three cognitive assessments in myeloma patients who undergo autologous stem cell transplant, and to determine if patients prefer the self-assessment, Self-Administered Gerocognitive Exam (SAGE) or the healthcare applied Montreal Cognitive Assessment (MoCA) assessment.

Key facts

Study ID: NCT03355235
Run by: Wake Forest University Health Sciences
People needed: 50
Starts: 2017-10-20
Expected to finish: 2019-08-27
Last updated by the study team: 2020-08-31

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

Patients with multiple myeloma
Patients who will undergo pre-transplant evaluation with intentions to proceed to autologous stem cell transplant after stem cell collection.
Patients willing and able to understand and sign an informed consent form
Patients 18 yrs of age or older

You may not qualify if…

Patients with unstable psychiatric illness within the past 3 months of study enrollment.
Patients who are considered unable to perform study evaluations at the investigator's discretion.
Patients who are unable to read. (If patients require reading glasses, they must be worn at time of test.)
Patients who do not proceed to stem cell transplant within 60 days of stem cell collection will be excluded from study.
Patients who receive more than one cycle of chemotherapy between the time of stem cell collection and transplant will be excluded from study.

Where it is running

Wake Forest University Health Sciences — Winston-Salem, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.